PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors
- PMID: 15547761
PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors
Abstract
Medulloblastoma, which accounts for 20-25% of all childhood brain tumors, is defined as a primitive neuroectodermal tumor (PNET) located in the cerebellum. Supratentorial PNET are less frequent than medulloblastoma. But their clinical outcome is worse than in medulloblastomas. Chromosome 10q contains at least 2 tumor suppressor genes that might play a role in brain tumor development: PTEN and DMBT1. The aim of this study was to compare the status of homozygous deletion and expression of PTEN and DMBT1 genes in PNET primary tumor samples and cell lines. Homozygous deletions of PTEN and DMBT1 were studied in 32 paraffin-embedded PNET samples (23 medulloblastomas and 9 supratentorial PNET) and in 7 PNET cell lines, by differential PCR and by FISH. PTEN homozygous losses were demonstrated in 7 medulloblastomas (32%) and in no supratentorial PNET, while homozygous deletions of DMBT1 appeared in 1 supratentorial PNET (20%) and in 7 medulloblastomas (33%). No homozygous deletion of PTEN or DMBT1 was detected in any of the PNET cell lines either by differential PCR or by FISH. Expression study of the 2 genes was performed in the 7 PNET cell lines by RT-PCR. One PNET cell line lacked PTEN and DMBT1 expression, while 2 medulloblastoma cell lines did not express DMBT1. Our results add some positive data to the hypothesis that supratentorial PNETs and medulloblastomas might be genetically different.
Similar articles
-
Homozygous deletion and expression of PTEN and DMBT1 in human primary neuroblastoma and cell lines.Int J Cancer. 2004 May 1;109(5):673-9. doi: 10.1002/ijc.20055. Int J Cancer. 2004. PMID: 14999773
-
Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.J Neurosurg Pediatr. 2010 Jun;5(6):608-14. doi: 10.3171/2010.2.PEDS1065. J Neurosurg Pediatr. 2010. PMID: 20515335
-
Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas.Genes Chromosomes Cancer. 2007 Sep;46(9):839-51. doi: 10.1002/gcc.20471. Genes Chromosomes Cancer. 2007. PMID: 17592618
-
[Molecular biological study of cerebellar medulloblastoma and supratentorial primitive neuroectodermal tumors].Zhonghua Bing Li Xue Za Zhi. 2003 Jun;32(3):271-3. Zhonghua Bing Li Xue Za Zhi. 2003. PMID: 14518436 Review. Chinese. No abstract available.
-
Animal models of medulloblastomas and related primitive neuroectodermal tumors. A review.J Neuropathol Exp Neurol. 1995 May;54(3):285-96. doi: 10.1097/00005072-199505000-00001. J Neuropathol Exp Neurol. 1995. PMID: 7745427 Review.
Cited by
-
A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes.Neuro Oncol. 2014 Jan;16(1):62-71. doi: 10.1093/neuonc/not162. Epub 2013 Dec 4. Neuro Oncol. 2014. PMID: 24311633 Free PMC article.
-
Matching mice to malignancy: molecular subgroups and models of medulloblastoma.Childs Nerv Syst. 2012 Apr;28(4):521-32. doi: 10.1007/s00381-012-1704-1. Childs Nerv Syst. 2012. PMID: 22315164 Free PMC article. Review.
-
PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.PLoS One. 2016 Mar 3;11(3):e0150836. doi: 10.1371/journal.pone.0150836. eCollection 2016. PLoS One. 2016. PMID: 26938241 Free PMC article.
-
Aggressive infantile embryonal tumors.J Child Neurol. 2008 Oct;23(10):1195-204. doi: 10.1177/0883073808321769. J Child Neurol. 2008. PMID: 18952586 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials